CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | Lewis William Chair and CEO | Sale 10b5-1 | −1,430 | $71.94 | $103K | 233,924 |
| 2025-06-02 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 157,160 | ||
| 2025-05-30 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −6,327 | $68.56 | $434K | 91,045 |
| 2025-05-30 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −20,000 | $70.00 | $1.4M | 71,045 |
| 2025-05-27 | SHAROKY MELVIN MD Director | Gift | −200 | 300,616 | ||
| 2025-05-21 | Desjardins Clarissa Director | Purchase | +1,130 | $66.35 | $75K | 3,025 |
| 2025-05-20 | SHAROKY MELVIN MD Director | Gift | −400 | 300,816 | ||
| 2025-05-20 | SHAROKY MELVIN MD Director | Gift | +100 | 100 | ||
| 2025-05-20 | SHAROKY MELVIN MD Director | Gift | +100 | 100 | ||
| 2025-05-20 | SHAROKY MELVIN MD Director | Gift | +100 | 100 | ||
| 2025-05-20 | SHAROKY MELVIN MD Director | Gift | +100 | 100 | ||
| 2025-05-20 | Desjardins Clarissa Director | Purchase | +1,895 | $66.87 | $127K | 1,895 |
| 2025-05-20 | Lewis William Chair and CEO | Sale 10b5-1 | −9,489 | $66.87 | $635K | 325,798 |
| 2025-05-20 | Lewis William Chair and CEO | Sale 10b5-1 | −4,480 | $67.96 | $304K | 321,318 |
| 2025-05-20 | Lewis William Chair and CEO | Sale 10b5-1 | −7,088 | $68.49 | $485K | 314,230 |
| 2025-05-20 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-05-20 | Lewis William Chair and CEO | Sale 10b5-1 | −2,863 | $66.90 | $192K | 237,891 |
| 2025-05-20 | Lewis William Chair and CEO | Sale 10b5-1 | −2,251 | $68.13 | $153K | 235,640 |
| 2025-05-20 | Lewis William Chair and CEO | Sale 10b5-1 | −1,716 | $68.54 | $118K | 233,924 |
| 2025-05-20 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 163,990 |
Page 24 of 42 · 826 trades